QuidelOrtho [QDEL] vs Artivion [AORT] Detailed Stock Comparison

QuidelOrtho Corporation

NASDAQ
Loading...

Artivion Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: QuidelOrtho Corporation wins in 8 metrics, Artivion Inc. wins in 11 metrics, with 0 ties. Artivion Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric QuidelOrtho Corporation Artivion Inc. Better
P/E Ratio (TTM) N/A 179.71 N/A
Price-to-Book Ratio 0.42 4.03 QuidelOrtho Corporation
Debt-to-Equity Ratio 148.60 57.67 Artivion Inc.
PEG Ratio 4.15 -1.59 QuidelOrtho Corporation
EV/EBITDA 6.23 36.67 QuidelOrtho Corporation
Profit Margin (TTM) -41.46% 2.21% Artivion Inc.
Operating Margin (TTM) 4.01% 8.09% Artivion Inc.
EBITDA Margin (TTM) 4.01% 8.09% Artivion Inc.
Return on Equity -46.15% 2.70% Artivion Inc.
Return on Assets (TTM) 1.27% 2.34% Artivion Inc.
Free Cash Flow (TTM) $-83.00M $839,000 Artivion Inc.
1-Year Return -57.55% -24.98% Artivion Inc.
Price-to-Sales Ratio (TTM) 0.30 4.15 QuidelOrtho Corporation
Enterprise Value $3.50B $1.97B QuidelOrtho Corporation
EV/Revenue Ratio 1.28 4.47 QuidelOrtho Corporation
Gross Profit Margin (TTM) 44.28% 63.06% Artivion Inc.
Revenue per Share (TTM) $40 $10 QuidelOrtho Corporation
Earnings per Share (Diluted) $-16.69 $0.21 Artivion Inc.
Beta (Stock Volatility) 0.92 1.62 QuidelOrtho Corporation
Short % of Float 31.16% 4.13% Artivion Inc.

QuidelOrtho Corporation vs Artivion Inc. Stock Performance Analysis

Loading Price Chart...

QDEL
AORT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
QuidelOrtho Corporation2.33%10.84%7.00%-41.19%-49.91%-53.82%
Artivion Inc.0.78%-11.94%-42.53%-47.03%-54.99%-54.07%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
QuidelOrtho Corporation-57.55%-84.89%-87.49%-22.50%-11.19%34.37%
Artivion Inc.-24.98%45.13%-23.19%88.21%317.89%366.18%

Performance & Financial Health Analysis: QuidelOrtho Corporation vs Artivion Inc.

MetricQDELAORT
Market Information
Market Cap i$765.24M$1.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,727,559273,552
90 Day Avg. Volume i2,559,683406,554
Last Close$13.60$20.58
52 Week Range$9.92 - $35.58$19.16 - $48.25
% from 52W High-61.78%-57.35%
All-Time High$306.72 (Aug 03, 2020)$48.25 (Dec 17, 2025)
% from All-Time High-95.57%-57.35%
Growth Metrics
Quarterly Revenue Growth0.02%0.19%
Quarterly Earnings Growth0.02%0.19%
Financial Health
Profit Margin (TTM) i-0.41%0.02%
Operating Margin (TTM) i0.04%0.08%
Return on Equity (TTM) i-0.46%0.03%
Debt to Equity (MRQ) i148.6057.67
Cash & Liquidity
Book Value per Share (MRQ)$28.28$9.37
Cash per Share (MRQ)$2.50$1.36
Operating Cash Flow (TTM) i$105.20M$39.88M
Levered Free Cash Flow (TTM) i$233.88M$-20,097,624
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: QuidelOrtho Corporation vs Artivion Inc.

MetricQDEL (Apr 24, 2026)AORT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A179.71
Forward P/E i4.1532.65
PEG Ratio i4.15-1.59
Price to Sales (TTM) i0.304.15
Price to Book (MRQ) i0.424.03
Market Capitalization
Market Capitalization i$765.24M$1.83B
Enterprise Value i$3.50B$1.97B
Enterprise Value Metrics
Enterprise to Revenue i1.284.47
Enterprise to EBITDA i6.2336.67
Risk & Other Metrics
Beta i0.921.62
Book Value per Share (MRQ) i$28.28$9.37

Financial Statements Comparison: QuidelOrtho Corporation vs Artivion Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricQDEL (2025)AORT (2025)
Revenue/Sales i2.73B441.33M
Cost of Goods Sold i1.46B157.10M
COGS % of Revenue i53.3%35.6%
Gross Profit i1.27B284.23M
Gross Margin i46.7%64.4%
Research & Development i186.20M30.99M
Operating Income (EBIT) i54.80M26.75M
Operating Margin i2.0%6.1%
EBITDA i488.50M59.48M
EBITDA Margin i17.9%13.5%
Pre-Tax Income i-1.11B14.78M
Pre-Tax Income % of Revenue i-40.6%3.3%
Income Tax i24.10M5.01M
Income Tax % of Revenue i0.9%1.1%
Net Income (Profit) i-1.13B9.77M
Profit Margin i-41.5%2.2%

Balance Sheet & Liquidity Metrics

MetricQDEL (2025)AORT (2025)
Cash & Equivalents i169.80M64.91M
Total Current Assets i1.45B358.08M
Total Current Assets % of Revenue i53.0%81.1%
Total Current Liabilities i966.10M101.56M
Total Current Liabilities % of Revenue i35.4%23.0%
Long-Term Debt i2.63B252.24M
Long-Term Debt % of Revenue i96.2%57.2%
Total Shareholders Equity i1.92B448.23M
Retained Earnings i-996.00M-51.50M
Retained Earnings % of Revenue i-36.5%-11.7%
Property, Plant & Equipment i1.06B34.70M

Cash Flow Statement Comparison

MetricQDEL (2025)AORT (2025)
Operating Cash Flow i-770.50M41.11M
Operating Cash Flow % of Revenue i-28.2%9.3%
Capital Expenditures i-188.20MN/A
Free Cash Flow i-83.00M839,000
FCF Margin i-3.0%0.2%
Debt Repayment i-2.41B-2.46M
Common Stock Repurchase i00

Short Interest & Institutional Ownership Analysis

MetricQDELAORT
Shares Short i12.79M1.67M
Short Ratio i7.644.28
Short % of Float i31.16%4.13%
Shares Outstanding i67.93M47.84M
Float Shares i63.58M45.40M
% Held by Insiders i1.01%4.52%
% Held by Institutions i115.01%91.48%
% Held by Public i-16.02%4.00%

Dividend Analysis & Yield Comparison: QuidelOrtho Corporation vs Artivion Inc.

MetricQDELAORT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A